The market for closed system transfer devices in terms of revenue was estimated to be worth $1.1 billion in 2024 and is poised to reach $2.5 billion by 2029, growing at a CAGR of 14.5% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Closed System Transfer Devices (CSTDs) are specialized tools designed to ensure the safe handling of hazardous drugs, particularly in healthcare settings such as pharmacies and hospitals. They provide a closed environment for the transfer of medications, preventing exposure to harmful substances for healthcare workers and reducing the risk of contamination.

The market for CSTDs has been steadily growing due to increasing awareness of the risks associated with handling hazardous drugs and the need for stringent safety measures in healthcare facilities. Factors such as stringent regulations, growing concerns about worker safety, and an increasing number of cancer cases driving chemotherapy drug usage contribute to the market's expansion.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=251802928

Browse in-depth TOC on "Closed System Transfer Devices Market”

150 – Tables

70 – Figures

250 – Pages

Key Market Players

The key players in the closed system transfer devices market include Becton, Dickinson and Company (US)ICU Medical, Inc. (US)Equashield LLC (US)Corning Incorporated (US)B Braun Melsungen AG (Germany)West Pharmaceuticals Services (US),Simplivia Healthcare (Israel)Corvida Medical (US),Yukon Medical (US)JMS Co., Ltd. (Japan)Baxter International (US)Terumo Corporation (Japan),Cardinal Health (US)Eraser Medical (Turkey)CODAN Medizinische Geräte GmbH (Germany)Victus (US), Caragen (Ireland)Vygon SA (US)Practivet (US), and Insung Medical (South Korea).

Driver: Increased Awareness of Occupational Hazards

The growing awareness of the occupational hazards associated with handling hazardous drugs in healthcare settings is a significant driver for the CSTD market. Healthcare organizations are increasingly recognizing the risks posed to healthcare workers, including exposure to carcinogens and reproductive toxins. Consequently, there's a heightened demand for safer handling practices, which boosts the adoption of CSTDs to mitigate these risks and ensure worker safety.

Request FREE Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=251802928

By closing mechanism, color-to-color alignment system is expected to show highest CAGR of closed system transfer devices industry from 2024 to 2029

The closing mechanism segment is classified into luer lock system, push-to-turn system, click-to-lock system, and color-to-color alignment system.

Color-to-color alignment system systems facilitate precise and efficient transfer of materials in closed environments, ensuring safety and accuracy in various industries such as pharmaceuticals, biotechnology, and chemical manufacturing. With an increasing emphasis on contamination control and stringent regulatory requirements, the demand for closed system transfer devices equipped with color-to-color alignment systems is expected to surge. As industries continue to prioritize safety and efficiency in their processes, the adoption of color-to-color alignment systems within closed system transfer devices is projected to experience robust growth in the foreseeable future.

Based on type, membrane-to-membrane systems are expected to have the largest market share in the closed system transfer devices Industry.

By type, the closed system transfer devices market is segmented into membrane-to-membrane systems and needleless systems. Membrane-to-membrane systems have a significant advancement in ensuring safe and efficient transfer of medications and fluids. With growing emphasis on stringent regulatory standards in healthcare settings, membrane-to-membrane systems are poised to witness substantial adoption, driven by their ability to mitigate risks associated with drug handling and administration, ultimately, this drives significant growth in the market.

Based on technology, diaphragm-based devices segment of closed system transfer devices industry is expected to show highest CAGR from 2024 to 2029

The technology segment is further divided into diaphragm-based devices, compartmentalized devices, and air cleaning/filtration devices.

Diaphragm-based devices are anticipated to undergo the highest CAGR within the closed system transfer devices market. This growth projection is primarily attributed to their superior performance in ensuring safe and efficient transfer of hazardous substances, medications, and fluids, thereby minimizing the risk of contamination and exposure among healthcare workers and patients. Diaphragm-based systems offer enhanced reliability, precision, and ease of use, making them increasingly favored for a wide range of applications in healthcare settings. With a growing emphasis on patient safety, coupled with advancements in technology and increasing awareness regarding the importance of CSTDs, the demand for diaphragm-based solutions is expected to surge, propelling their market growth at an accelerated pace.

Based on components, vial access components segment of closed system transfer devices industry is expected to show highest CAGR from 2024 to 2029

The closed system transfer devices market, based on component, is segmented into vial access components, male luers, bag spikes, female components, and other components.

Vial access components play a crucial role in ensuring the integrity of drug transfer processes within closed systems, thereby minimizing the risk of contamination and exposure to harmful substances for healthcare workers and patients. The rising adoption of CSTDs across various healthcare settings, driven by stringent regulatory guidelines and heightened awareness regarding the importance of safe drug administration, is likely to propel the demand for vial access components, thus contributing to their projected high CAGR within the closed system transfer devices market.

By end user, hospitals & clinics segment accounted for the largest share of closed system transfer devices industry from 2024 to 2029

End users segment in the closed system transfer devices market is further classified into hospitals & clinics, oncology centers, and other end users.

Hospitals and clinics serve as primary points of care for patients requiring a wide range of medical treatments and procedures, thereby necessitating a higher demand for safety measures such as closed system transfer devices to prevent contamination and exposure to hazardous drugs. Moreover, the stringent regulatory standards enforced in healthcare facilities mandate the adoption of safe handling practices, prompting hospitals and clinics to invest in advanced technologies like CSTDs to ensure compliance and patient safety. Consequently, the collective demand from hospitals and clinics significantly contributes to their substantial market share in the CSTD market within the healthcare industry.

The research report categorizes closed system transfer devices market to forecast revenue and analyze trends in each of the following submarkets:

By Component

  • Vial access components
  • Male Luers
  • Bag Spikes
  • Female Components
  • Other Components

By Technology

  • Diaphragm-based devices
  • Compartmentalized devices
  • Air cleaning/filtration devices

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Colombia
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • Rest of Middle East and Africa

Request 10% Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=251802928

Recent Developments of Closed System Transfer Devices Industry:

  • In January 2022, ICU Medical, Inc. (US) acquired Smiths Medical with the aim of broadening its product portfolio with the inclusion of syringe & ambulatory infusion devices, vascular access, and vital care products.
  • In March 2022, Baxter International (US) entered into an agreement with a subsidiary of Pfizer Inc. to acquire the rights to Zosyn, a premixed frozen piperacillin-tazobactam product, to be supplied in North America. This product is used for the treatment of intra-abdominal infections, nosocomial pneumonia, skin and skin structure infections, female pelvic infections, and community-acquired pneumonia.
  • In October 2023, EQUASHIELD LLC. (US) Syringe Unit received additional FDA clearance for full-volume use. This approval results in a cost-effective solution for medication compounding & administrating requirements.
  • In March 2022, Vygon SA(France) acquired Macatt Medica, a distribution company located in Lima, Peru, boosting Vygon’s presence in South America. The company sells the bulk of Vygon's products in Peru, including a line of enteral nutrition products.